Dr David Lawrence

Thursday, March 30 2017 at 7:30PM

Download iCalendar file
(e.g. import to Outlook or Google Calendar)


39 Ditchling Road

Dr David Lawrence

What's the talk about?

 Since the 1980s there have been a number of huge developments in the fight against HIV/AIDS. As antiretroviral therapy has become more effective and less harmful to patients we can now expect those in the UK who are diagnosed with HIV to have a near normal life expectancy. A large number of the gains made in this field have been a credit to the lobbying and activism of the LGBT community around the world who pushed for increased global access to treatment. 

An emerging trend in this field is the use of pre-exposure prophylaxis (PrEP), a single tablet which, when taken by HIV negative individuals, can greatly reduce the chance of catching HIV. Although not available on the NHS, increasing availability of PrEP online has prompted some concerns that this will lead to relaxed safe sex practices, increased rates of other sexually transmitted infections and, if taken incorrectly, PrEP may contribute to drug resistance. Although not much of a sceptic, Dr David Lawrence will talk us through the journey which has brought us to this point, explain the key research findings, and provide an update on the current debates surrounding this treatment.
David Lawrence is a junior doctor specialising in HIV and sexual health. He has worked at the Royal Sussex County Hospital since 2012 and has previously worked for a number of large charities which work to promote sexual and reproductive rights around the globe.